Glucagon-like peptide-1 receptor agonists do not decrease the risk of coronary revascularization in patients with type 2 diabetes-MedSci.cn - 梅斯（MedSci）

Glucagon-like peptide-1 receptor agonists do not decrease the risk of coronary revascularization in patients with type 2 diabetes

Patoulias, D; Papadopoulos, C; Kassimis, G; Doumas, M

Patoulias, D (通讯作者)，Gen Hosp Hippokrat, Propedeut Dept Internal Med 2, Konstantinoupoleos 49, Washington 54642, Greece.

CORONARY ARTERY DISEASE, 2022; 33 (5): 427

科室
- - 订阅+
  - 更多科室
工具
服务